Browsing: Targets

The BC-APPS1 studyThe BC-APPS1 was a single-arm, single-centre phase II study registered under the name ‘a pilot prevention study of…

A new recombinant antivenom that targets multiple venomous snake species—including the African spitting cobra, shown here—could lead to both safer…

This sector is growing faster than many other markets with a compound annual growth rate (CAGR) of 4% and countries…

Founded by entrepreneur Balazs Farkas-Jenser, Vivorum is built on the philosophy that sleep is the foundation of mental wellbeing and…

SEVILLE – It was fitting that the European Society of Gene and Cell Therapy (ESGCT) invited the noted Spanish stem…

Credit: FG Trade/Getty Images The first large-scale study to look at gene expression in brain tissue from African American donors…

The move reflects growing demand for evidence-backed fertility and prenatal supplements outside of traditional clinical settings, as industry stakeholders respond…

Cirrus Therapeutics lands seed funding to advance gene therapy designed to prevent and reverse dry AMD by rejuvenating the retina.…

Biograph partners with Caristo Diagnostics to bring CaRi-Heart to the US and open preventive pathways in cardiology. Cardiovascular disease remains…

Treating the brain cancer glioblastoma (GBM) demands more than conventional strategies due to a mix of factors including the cancer’s…